Lead Product(s) : Mirogabalin Besylate
Therapeutic Area : Neurology
Study Phase : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Tarlige® Tablets Approved in Japan for Treatment of Patients with Neuropathic Pain
Details : Tarlige® (mirogabalin besilate), is an analgesic works by inhibiting the excessive release of pain-related neurotransmitters in presynaptic nerve terminal, ® was approved for the indication of “peripheral neuropathic pain” in Japan.
Brand Name : Tarlige
Molecule Type : Small molecule
Upfront Cash : Not Applicable
March 28, 2022
Lead Product(s) : Mirogabalin Besylate
Therapeutic Area : Neurology
Highest Development Status : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
LOOKING FOR A SUPPLIER?
Reset All
